首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Increasing the dialysate sodium concentration based on serum sodium concentrations exacerbates weight gain and thirst in hemodialysis patients
【24h】

Increasing the dialysate sodium concentration based on serum sodium concentrations exacerbates weight gain and thirst in hemodialysis patients

机译:根据血清钠浓度增加透析液钠浓度会加剧血液透析患者的体重增加和口渴

获取原文
获取原文并翻译 | 示例
           

摘要

Most dialysis centers adopt a standard dialysate sodium prescription. While pre-hemodialysis (HD) serum sodium levels remain relatively constant in each individual patient on chronic HD, these levels can vary between different patients. Therefore, a single dialysate sodium prescription may not be appropriate for all patients. Nineteen stable patients on maintenance HD were dialyzed for 9 HD sessions with their current dialysis solutions, followed by another 9 sessions using individualized prescriptions created by aligning dialysate sodium levels to each patient's serum sodium concentration. Patients were divided into 2 groups according to whether the average pre-HD serum sodium concentration was higher than (higher serum sodium group, n = 13) or equal to (equal sodium group, n = 5) the standard dialysate sodium concentration. Pre-HD serum sodium levels remained constant during entire study period in both groups. In higher serum sodium group, interdialytic weight gain increased after implementation of the sodium alignment (2.0 ± 0.3 kg vs. 2.3 ± 0.4 kg; P = 0.008). Thirst scores also increased in patients whose dialysate sodium was increased by 4 mmol/L (n = 7) (6.4 ± 1.5 vs. 7.6 ± 1.5, P = 0.015). There were no significant changes in blood pressure and intradialytic complications. In equal sodium group, significant differences were not observed in any parameters. Our results suggest that alignment of dialysate sodium levels to each patient's serum sodium concentration is of little benefit in hemodynamically stable patients who have pre-HD serum sodium concentrations higher than dialysate sodium concentration.
机译:大多数透析中心采用标准的透析液钠处方。血液透析前(HD)血清钠水平在每位慢性HD患者中保持相对恒定,但这些水平在不同患者中可能有所不同。因此,单一透析液钠处方可能并不适合所有患者。 19名维持HD的稳定患者使用其当前的透析溶液透析9次HD,然后使用通过将透析液钠水平与每位患者的血清钠浓度相匹配而创建的个性化处方再进行9次透析。根据HD前平均血清钠浓度是否高于(透析液钠高组,n = 13)或等于(透析液钠组,n = 5)标准透析液钠浓度,将患者分为两组。两组的整个研究期间,HD前血清钠水平均保持恒定。在较高的血清钠组中,实施钠比对后,透析间增重增加(2.0±0.3 kg vs. 2.3±0.4 kg; P = 0.008)。透析液钠增加4 mmol / L(n = 7)的患者口渴评分也有所提高(6.4±1.5 vs. 7.6±1.5,P = 0.015)。血压和透析内并发症无明显变化。在相等的钠组中,任何参数均未观察到显着差异。我们的结果表明,透析前血钠浓度高于透析钠浓度的血液动力学稳定患者,透析液钠水平与每位患者血清钠浓度的一致性几乎没有益处。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号